DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use
May 08, 2021, at 11:57 pm
New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.
India's Glenmark launches first oral antiviral drug FabiFlu to treat COVID-19 patients
Jun 21, 2020, at 01:23 pm
New Delhi/IBNS: Amid the massive spike in number of cases, India-based pharmaceutical company 'Glenmark Pharmaceuticals' has launched antiviral drug Favipiravir, to be sold under the brand name FabiFlu, for the treatment of patients having mild to moderate COVID-19 symptoms.